Suchergebnisse - "O'Connor, Owen A"

PubPharm (116)

1

Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies

enthalten in: Blood | 2017

von Deng, C. | Lipstein, M. | Scotto, L. | +15

2

A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab

enthalten in: British journal of haematology | 2017

von Sawas, A. | Farber, C. | Schreeder, M. | +10

3

A phase 1/2 trial of ublituximab, a novel anti‐CD20 monoclonal antibody, in patients with B‐cell non‐Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab

enthalten in: British journal of haematology | 2017

von Sawas, A. | Farber, C. | Schreeder, M. | +10

4

Post‐transplant lymphoproliferative disorder: a heterogeneous conundrum – response to Weisenburger DD & Gross TG

enthalten in: British journal of haematology | 2017

von Radeski, D. | Montanari, F. | Alobeid, B. | +2

5

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

enthalten in: Clinical cancer research | 2016

von Shah, J. | Jakubowiak, A. | O'Connor, O. | +13

6

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

enthalten in: Leukemia & lymphoma | 2016

von Bartlett, N. | Smith, M. | Siddiqi, T. | +13

7

Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma

enthalten in: British journal of haematology | 2016

von Kalac, M. | Lue, J. | Lichtenstein, E. | +9

8

Emerging therapies in relapsed and refractory peripheral T-cell lymphoma

enthalten in: Clinical advances in hematology & oncology : H&O | 2015

von Bachow, S. | O'Connor, O.

9

Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection

enthalten in: Leukemia & lymphoma | 2015

von Fogli, L. | Williams, M. | Connors, J. | +3

10

Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

enthalten in: Leukemia & lymphoma | 2015

von Forero-Torres, A. | Bartlett, N. | Berryman, R. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]